pentobarbital will reduce the extent or influence of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Use of different treatment plans is strongly advisable when linagliptin is to be administered with a CYP3A4 inducer

pentobarbital will decrease the extent or influence of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will lessen the extent or influence of theophylline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will minimize the level or effect of pantoprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.

pentobarbital will decrease the level or result of levoketoconazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.

pentobarbital will minimize the level or outcome of temsirolimus by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

Contraindicated (one)pentobarbital decreases amounts of panobinostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers can decrease panobinostat ranges by ~70% and bring about treatment method failure.

pentobarbital will decrease the level or outcome of avanafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. For patients with ED, keep track of reaction thoroughly as a consequence of potential for diminished usefulness.

pentobarbital will decrease the extent or outcome of venetoclax by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the extent or effect of diazepam buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Sturdy or reasonable CYP3A4 inducers may possibly increase fee of diazepam elimination; consequently, efficacy of diazepam might be lowered.

pentobarbital will decrease the extent or influence of atazanavir by impacting more info hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.

pentobarbital will reduce the extent or outcome of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.

Barbiturates can induce hepatic microsomal enzymes causing elevated metabolism and diminished anticoagulant reaction of oral anticoagulants (eg, warfarin, acenocoumarol, dicumarol, and phenprocoumon); individuals stabilized on anticoagulant therapy could require dosage adjustments if barbiturates are additional to or withdrawn from their dosage regimen

pentobarbital will lower the level or effect of alosetron by influencing hepatic enzyme CYP2C9/10 metabolism. Small/Importance Not known.